GO6979

GO6979 is a **synthetic small molecule inhibitor** primarily used in research to **inhibit specific isoforms of protein kinase C (PKC)**, with notable activity against **PKC-alpha and PKC-beta**. It is frequently used as a **biochemical tool** to study PKC-dependent signaling pathways, cell migration, differentiation, and function in cell and animal models. GO6979 is not approved for clinical or therapeutic use in humans; its use is restricted to laboratory research applications. Mechanistically, GO6979 is a **selective ATP-competitive inhibitor** of PKC, blocking kinase activity and downstream cellular responses involved in immune signaling, cancer biology, angiogenesis, and inflammation[3][7].